Literature DB >> 27990740

Hypertensive eye disease: a review.

Samantha Fraser-Bell1,2,3, Richard Symes1,3, Anagha Vaze1.   

Abstract

Hypertension is a risk factor for a number of vision-threatening eye conditions including retinal vascular occlusion, retinal macroaneurysm and non arteritic anterior ischaemic optic neuropathy. In addition, hypertension may exacerbate the vision-threatening effects of diabetic retinopathy and has been implicated in the pathogenesis of age-related macular degeneration. The effects of sustained hypertension are directly visible in the eye as hypertensive retinopathy and choroidopathy, reflecting a pathological process occurring throughout the body. Close collaboration between ophthalmologists and general practitioners/physicians is needed to ensure that hypertensive patients are identified and treated. Timely intervention in these patients may reduce the risk of both vision-threatening and systemic complications.
© 2016 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  hypertension; retina; retinopathy

Mesh:

Year:  2017        PMID: 27990740     DOI: 10.1111/ceo.12905

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  23 in total

1.  Ablation of Immunoproteasome β5i Subunit Suppresses Hypertensive Retinopathy by Blocking ATRAP Degradation in Mice.

Authors:  Shuai Wang; Jing Li; Tong Wang; Jie Bai; Yun-Long Zhang; Qiu-Yue Lin; Jing-Min Li; Qi Zhao; Shu-Bin Guo; Hui-Hua Li
Journal:  Mol Ther       Date:  2019-10-05       Impact factor: 11.454

2.  Increased choroidal blood flow and choroidal thickness in patients with hypertensive chorioretinopathy.

Authors:  Michiyuki Saito; Kousuke Noda; Wataru Saito; Kiriko Hirooka; Yuki Hashimoto; Susumu Ishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-14       Impact factor: 3.117

3.  Longitudinal Associations Between Vision Impairment and the Incidence of Neuropsychiatric, Musculoskeletal, and Cardiometabolic Chronic Diseases.

Authors:  Ajay Kolli; Kristian Seiler; Neil Kamdar; Lindsey B De Lott; Mark D Peterson; Michelle A Meade; Joshua R Ehrlich
Journal:  Am J Ophthalmol       Date:  2021-09-20       Impact factor: 5.258

4.  Hypertension secondary to nitric oxide depletion produces oxidative imbalance and inflammatory/fibrotic outcomes in the cornea of C57BL/6 mice.

Authors:  Álvaro Santana-Garrido; Claudia Reyes-Goya; Ana Arroyo-Barrios; Helder André; Carmen M Vázquez; Alfonso Mate
Journal:  J Physiol Biochem       Date:  2022-08-09       Impact factor: 5.080

5.  Multimorbidity and multi-disability among the elderly in residential care in India: the Hyderabad Ocular Morbidity in Elderly Study (HOMES).

Authors:  Srinivas Marmamula; Thirupathi Reddy Kumbham; Rahul Shidhaye; Satya Brahmanandam Modepalli; Navya Rekha Barrenkala; Ratnakar Yellapragada; Jill Keeffe
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

Review 6.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

Review 7.  A Review of Hypertensive Retinopathy and Chorioretinopathy.

Authors:  Mai Tsukikawa; Andrew W Stacey
Journal:  Clin Optom (Auckl)       Date:  2020-05-05

8.  Novel Classification of Early-stage Systemic Hypertensive Changes in Human Retina Based on OCTA Measurement of Choriocapillaris.

Authors:  Kei Takayama; Hiroki Kaneko; Yasuki Ito; Keiko Kataoka; Takeshi Iwase; Tetsuhiro Yasuma; Toshiyuki Matsuura; Taichi Tsunekawa; Hideyuki Shimizu; Ayana Suzumura; Eimei Ra; Tomohiko Akahori; Hiroko Terasaki
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

9.  Acute Hypertensive Retinochoroidopathy Secondary to an Anti-cancer Drug (apatinib): The First Case Report.

Authors:  Bangtao Yao; Gang Liu; Bei Wang; Qian Cao
Journal:  Front Med (Lausanne)       Date:  2021-06-23

10.  Cardiovascular risk factors as determinants of retinal and skin microvascular function: The Maastricht Study.

Authors:  Ben M Sörensen; Alfons J H M Houben; Tos T J M Berendschot; Jan S A G Schouten; Abraham A Kroon; Carla J H van der Kallen; Ronald M A Henry; Annemarie Koster; Pieter C Dagnelie; Nicolaas C Schaper; Miranda T Schram; Coen D A Stehouwer
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.